Kate E. Rogers

Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model

Phillip J. Bergen, Jürgen B. Bulitta, Carl M. J. Kirkpatrick et al. · Antimicrobial Agents and Chemotherapy · 2017 · 45 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17

Optimization of a Meropenem-Tobramycin Combination Dosage Regimen against Hypermutable and Nonhypermutable Pseudomonas aeruginosa via Mechanism-Based Modeling and the Hollow-Fiber Infection Model

Cornelia B. Landersdorfer, Vanessa Emily Rees, Rajbharan Yadav et al. · Antimicrobial Agents and Chemotherapy · 2018 · 43 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients

Vanessa Emily Rees, Rajbharan Yadav, Kate E. Rogers et al. · Antimicrobial Agents and Chemotherapy · 2018 · 41 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of different renal function on antibacterial effects of piperacillin against<i>Pseudomonas aeruginosa</i>evaluated via the hollow-fibre infection model and mechanism-based modelling

Phillip J. Bergen, Jürgen B. Bulitta, Carl M. J. Kirkpatrick et al. · Journal of Antimicrobial Chemotherapy · 2016 · 40 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Optimization and Evaluation of Piperacillin-Tobramycin Combination Dosage Regimens against Pseudomonas aeruginosa for Patients with Altered Pharmacokinetics via the Hollow-Fiber Infection Model and Mechanism-Based Modeling

Rajbharan Yadav, Kate E. Rogers, Phillip J. Bergen et al. · Antimicrobial Agents and Chemotherapy · 2018 · 27 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16